Clinical Trials

200 enrolled

CNS

Glioblastoma

NCT07467330 2026-03-12

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

258 enrolled

Breast Neoplasms

NCT07413809 2026-02-17

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

92 enrolled

Plasma cell

Multiple Myeloma

NCT05827523 2026-02-13

FOCUS / KOV-04

520 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT04073706 2026-01-30

ENDO-3

760 enrolled

Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

NCT07047456 2025-12-23

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT

134 enrolled

Other

Acute Graft Versus Host Disease

NCT06520163 2025-12-04

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

99 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT06940947 2025-11-20

ETHOS

434 enrolled

Colonic Neoplasms

NCT04776655 2025-10-02

LIBImAb

280 enrolled

Colorectal Neoplasms

NCT07185672 2025-09-22

PReCedeNT

162 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT05236946 2025-09-10

Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT

190 enrolled

Thoracic

Asymptomatic Brain Metastases

NCT05278052 2025-09-10

TARGET-02

190 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06793917 2025-07-20

Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

269 enrolled

Stomach Neoplasms

NCT07057427 2025-07-09

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

812 enrolled

Breast Neoplasms

NCT07050043 2025-07-03

LEDANG

123 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06156514 2025-05-28

MICHELE

140 enrolled

Gynecologic

Locally Advanced Cervical Cancer

NCT04328948 2025-05-22

ARMADILLO

280 enrolled

Esophageal Squamous Cell Carcinoma

NCT01785420 2025-04-09

Pre Operative Trastuzumab in Operable Breast Cancer

1,100 enrolled

Breast Neoplasms

NCT06565247 2025-03-04

Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT06737822 2025-03-04

SurVIC

346 enrolled

Head & Neck

Head and Neck Neoplasms, Mouth Neoplasms

NCT04214990 2024-12-27

EASTERN

1,700 enrolled

Stomach Neoplasms

NCT05477589 2024-12-19

SCRIPT-AML

Other hematologic neoplasm

170 enrolled

Leukemia, Neoplasms, Leukemia, Myeloid, Acute

NCT06519266 2024-11-25

SCANDIUM-III

40 enrolled

Dermatologic

Uveal Melanoma

NCT05063136 2024-11-04

Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

1,979 enrolled

Breast Neoplasms

NCT05495152 2024-10-02

Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma

219 enrolled

Esophageal Squamous Cell Carcinoma

NCT05769868 2024-10-01

CIBERbBECHO

1,000 enrolled

Diabetes Mellitus, Fibrosis

NCT04547907 2024-09-20

A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

688 enrolled

Breast Cancer,HER2-positive

NCT06520176 2024-07-25

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

99 enrolled

Plasma cell

Multiple Myeloma

NCT06226857 2024-01-29

CRC01

355 enrolled

Colorectal Neoplasms

NCT04280822 2022-10-04

Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma

400 enrolled

Esophageal Neoplasms

NCT04138212 2022-08-09

HCHTOG1903

456 enrolled